Axsome Therapeutics (AXSM)
(Delayed Data from NSDQ)
$65.72 USD
-3.99 (-5.72%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $66.54 +0.82 (1.25%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/06/2024
Time: BMO |
3/2024 | $-1.21 | -6.90% |
Earnings Summary
For their last quarter, Axsome Therapeutics (AXSM) reported earnings of -$0.73 per share, beating the Zacks Consensus Estimate of $-1.21 per share. This reflects a positive earnings surprise of 39.67%. Look out for AXSM's next earnings release on May 06, 2024. For the next earning release, we expect the company to report earnings of -$1.21 per share, reflecting a year-over-year decrease of 450%.
Earnings History
Price & Consensus
Zacks News for AXSM
Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
AXSM: What are Zacks experts saying now?
Zacks Private Portfolio Services